‘The last bridge’- How patients experience the CAR T-cell therapy. A qualitative study

CAR T-cell therapy gives patients new hope, who are diagnosed with relapsed or refractory B-cell lymphoma or B-cell leukaemia. To date, there is no scientific knowledge about the experiences of patients with CAR T-cell therapy, their process of treatment decision making or how they handle potential side effects. The study aims at deepening the understanding of the patient's experiences, indicating how to improve nursing care for this patient population.
Source: European Journal of Oncology Nursing - Category: Cancer & Oncology Authors: Source Type: research